These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 26438493)
1. Esters of Pyrazinoic Acid Are Active against Pyrazinamide-Resistant Strains of Mycobacterium tuberculosis and Other Naturally Resistant Mycobacteria In Vitro and Ex Vivo within Macrophages. Pires D; Valente E; Simões MF; Carmo N; Testa B; Constantino L; Anes E Antimicrob Agents Chemother; 2015 Dec; 59(12):7693-9. PubMed ID: 26438493 [TBL] [Abstract][Full Text] [Related]
2. Lipophilic pyrazinoic acid amide and ester prodrugs stability, activation and activity against M. tuberculosis. Simões MF; Valente E; Gómez MJ; Anes E; Constantino L Eur J Pharm Sci; 2009 Jun; 37(3-4):257-63. PubMed ID: 19491013 [TBL] [Abstract][Full Text] [Related]
3. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of Mycobacterium tuberculosis to pyrazinamide. Zhang Y; Scorpio A; Nikaido H; Sun Z J Bacteriol; 1999 Apr; 181(7):2044-9. PubMed ID: 10094680 [TBL] [Abstract][Full Text] [Related]
5. The pncA gene from naturally pyrazinamide-resistant Mycobacterium avium encodes pyrazinamidase and confers pyrazinamide susceptibility to resistant M. tuberculosis complex organisms. Sun Z; Scorpio A; Zhang Y Microbiology (Reading); 1997 Oct; 143 ( Pt 10)():3367-3373. PubMed ID: 9353938 [TBL] [Abstract][Full Text] [Related]
6. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide. Sun Z; Zhang Y Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of pyrazinamide resistance in mycobacteria: importance of lack of uptake in addition to lack of pyrazinamidase activity. Raynaud C; Lanéelle MA; Senaratne RH; Draper P; Lanéelle G; Daffé M Microbiology (Reading); 1999 Jun; 145 ( Pt 6)():1359-1367. PubMed ID: 10411262 [TBL] [Abstract][Full Text] [Related]
8. In Vivo-Selected Pyrazinoic Acid-Resistant Mycobacterium tuberculosis Strains Harbor Missense Mutations in the Aspartate Decarboxylase PanD and the Unfoldase ClpC1. Gopal P; Tasneen R; Yee M; Lanoix JP; Sarathy J; Rasic G; Li L; Dartois V; Nuermberger E; Dick T ACS Infect Dis; 2017 Jul; 3(7):492-501. PubMed ID: 28271875 [TBL] [Abstract][Full Text] [Related]
10. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide. Speirs RJ; Welch JT; Cynamon MH Antimicrob Agents Chemother; 1995 Jun; 39(6):1269-71. PubMed ID: 7574514 [TBL] [Abstract][Full Text] [Related]
11. QSAR modeling of a set of pyrazinoate esters as antituberculosis prodrugs. Fernandes JP; Pasqualoto KF; Felli VM; Ferreira EI; Brandt CA Arch Pharm (Weinheim); 2010 Feb; 343(2):91-7. PubMed ID: 20099263 [TBL] [Abstract][Full Text] [Related]
12. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance. Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792 [TBL] [Abstract][Full Text] [Related]
13. Metallochaperones Are Needed for Mycobacterium tuberculosis and Escherichia coli Nicotinamidase-Pyrazinamidase Activity. Sheen P; Monsalve A; Campos J; Huerta R; Antiparra R; Arteaga H; Duran P; Bueno C; Kirwan DE; Gilman RH; Zimic M J Bacteriol; 2020 Jan; 202(2):. PubMed ID: 31636108 [No Abstract] [Full Text] [Related]
14. Identification of Novel Efflux Proteins Rv0191, Rv3756c, Rv3008, and Rv1667c Involved in Pyrazinamide Resistance in Mycobacterium tuberculosis. Zhang Y; Zhang J; Cui P; Zhang Y; Zhang W Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584158 [TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide and Pyrazinoic Acid Derivatives Directed to Mycobacterial Enzymes Against Tuberculosis. Corrêa MF; Fernandes JP Curr Protein Pept Sci; 2016; 17(3):213-9. PubMed ID: 26427385 [TBL] [Abstract][Full Text] [Related]
16. Antimycobacterial activity of a series of pyrazinoic acid esters. Cynamon MH; Klemens SP; Chou TS; Gimi RH; Welch JT J Med Chem; 1992 Apr; 35(7):1212-5. PubMed ID: 1560435 [TBL] [Abstract][Full Text] [Related]
18. A new approach for pyrazinamide susceptibility testing in Mycobacterium tuberculosis. Zimic M; Loli S; Gilman RH; Gutierrez A; Fuentes P; Cotrina M; Kirwan D; Sheen P Microb Drug Resist; 2012 Aug; 18(4):372-5. PubMed ID: 22372927 [TBL] [Abstract][Full Text] [Related]
19. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan. Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001 [TBL] [Abstract][Full Text] [Related]
20. A novel inexpensive electrochemical sensor for pyrazinoic acid as a potential tool for the identification of pyrazinamide-resistant Rueda D; Furukawa R; Fuentes P; Comina G; Rey De Castro NG; Requena D; Gilman RH; Sheen P; Zimic M Int J Mycobacteriol; 2018; 7(3):275-281. PubMed ID: 30198510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]